Clinical trial
Efficacy and Safety of Latanoprost/Timolol Fixed Combination Dosed Twice Daily Compared to Once Daily in Patients With Primary Open Angle Glaucoma
NCT04098861 is registered in ClinicalTrials.gov with Universiti Kebangsaan Malaysia Medical Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Latanoprost/Timolol Fixed Combination Dosed Twice Daily Compared to Once Daily in Patients With Primary Open Angle Glaucoma
- Lead sponsor
- Universiti Kebangsaan Malaysia Medical Centre
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 2, 2019
- Completion date
- December 1, 2020
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary open angle glaucoma